Human Papillomavirus Anal Infection

Not Applicable

Completed

• Conditions: HPV Infection

• Registration Number: NCT02862795
• Lead Sponsor: Centre Hospitalier Universitaire de Besancon

Brief Summary

Human papillomavirus (HPV) are involved in up to 95 % of anal canal neoplastic lesions. Little is known about HPV carriage in anal canal previous to cancer occurrence in the population and pre-neoplastic lesions, and their risk factors. PAPILLAN is a prospective study that aims to study HPV infection (HPV low grade and high grade genotypes) prevalence in anal canal in a population non selected by its HIV status. In that purpose patients are prospectively recruited in a french university hospital gastroenterology unit and anal smears are collected during a colonoscopy with cytobrush.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-04
• Primary Completion: 2016-06
• Study Completion: 2016-06
• Status Verified: 2016-08
• Study First Submitted: 2016-08-04
• Study First Submitted QC: 2016-08-10
• Last Update Submitted: 2016-08-10
• Study First Posted: 2016-08-11
• Last Update Posted: 2016-08-11

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

• patients > 18 years
• patients undergoing colonoscopy under general anesthesia for any purpose
• signed written consent

Exclusion Criteria

• age under 18
• Absence of written consent.
• patients incapable of giving consent

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
anal canal HPV infection	at inclusion (the day of colonoscopy)

Trial Locations

Locations (2)

Centre Hospitalier Régional Universitaire de Besançon; 🇫🇷 Besançon, France

Centre Hospitalier Intercommunal de la Haute Saône; 🇫🇷 Vesoul, France